ZAVICEFTA subst sèche 2 g/0.5 g flac 10 pce
7680668900015
CH-66890
J01DD52
08.01.93
Reimbursement limitations:
ZAVICEFTA2
La pose de l’indication et l’instauration du traitement par ZAVICEFTA doivent être effectuées exclusivement à …
1 / 3
google
Details
- Product number
- 6689001
- CPT
- -
- Packaging group
- 10
- Unit
- Durchstechflasche(n)
- Composition
- Praeparatio sicca: ceftazidimum 2 g ut ceftazidimum pentahydricum, avibactamum 500 mg ut avibactamum natricum, natrii carbonas pro vitro corresp. natrium 145 mg.
Articles (1)
Zavicefta, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
10
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRS
|
2.0 G | Substance | Wirkstoff (Principe actif) |
|
PRS
|
- | Substance | WIZUS |
|
PRS
|
500.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRS
|
- | Substance | WIZUS |
|
PRS
|
- | Substance | HNIDK |
|
PRS
|
145.0 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 1268.55
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/05/2020
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 66890
- Drug name
- Zavicefta, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- PULPI
- ATC Code
- J01DD52
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 05/06/2019
- Authorization expiration date
- 31/12/9999
- IT number
- 08.01.93
- Domain
- Human medicine
Packaging details
- Description (FR)
- ZAVICEFTA subst sèche 2 g/0.5 g flac 10 pce
- Description (DE)
- ZAVICEFTA Trockensub 2 g/0.5 g Durchstf 10 Stk
- Market launch
- 05/06/2019
- Narcotic (BTM)
- No